Marcella Manerba
Italian Institute of Technology(IT)
Publications by Year
Research Areas
Cancer, Hypoxia, and Metabolism, DNA Repair Mechanisms, PARP inhibition in cancer therapy, Metabolism, Diabetes, and Cancer, ATP Synthase and ATPases Research
Most-Cited Works
- → Galloflavin (CAS 568‐80‐9): A Novel Inhibitor of Lactate Dehydrogenase(2011)193 cited
- → Galloflavin, a new lactate dehydrogenase inhibitor, induces the death of human breast cancer cells with different glycolytic attitude by affecting distinct signaling pathways(2012)150 cited
- → Inhibition of Lactate Dehydrogenase Activity as an Approach to Cancer Therapy(2014)97 cited
- → Lactate dehydrogenase inhibitors can reverse inflammation induced changes in colon cancer cells(2016)75 cited
- → Impairment of Aerobic Glycolysis by Inhibitors of Lactic Dehydrogenase Hinders the Growth of Human Hepatocellular Carcinoma Cell Lines(2010)60 cited
- → Galloflavin suppresses lactate dehydrogenase activity and causes MYC downregulation in Burkitt lymphoma cells through NAD/NADH-dependent inhibition of sirtuin-1(2013)51 cited
- → Rad51/BRCA2 disruptors inhibit homologous recombination and synergize with olaparib in pancreatic cancer cells(2019)50 cited
- → Synthetic Lethality in Pancreatic Cancer: Discovery of a New RAD51-BRCA2 Small Molecule Disruptor That Inhibits Homologous Recombination and Synergizes with Olaparib(2020)49 cited
- → Lactate dehydrogenase inhibitors sensitize lymphoma cells to cisplatin without enhancing the drug effects on immortalized normal lymphocytes(2015)44 cited
- → Inhibition of lactic dehydrogenase as a way to increase the anti-proliferative effect of multi-targeted kinase inhibitors(2010)41 cited